Simplifying Global Compliance
More Clarity on Roles, Terminology Sought on IRB Draft Guidance
Devices & Diagnostics Letter
Industry and patient advocacy groups are asking the FDA to clarify roles and terminologies in its recent draft guidance on oversight of investigators and sites and IND approvability.
To View This Article:
Subscribe To Devices & Diagnostics Letter
Buy This Article Now
Copyright ©2018. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing